Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Bohdan Nosyk

Datos Biográficos

ID1728094
NOMBREBohdan Nosyk
NOMBRESBohdan
APELLIDONosyk
FIRMANOSYK B
AFILIACIONESSimon Fraser University
ORCID0000-0003-2513-3718
VERIFICADOSí
TOTAL DE OBRAS23
TOTAL DE CITAS3
TOTAL COMO AUTOR23
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2007
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H1
  • Implementation of risk mitigation prescribing during dual public health emergencies

    Open Access•Brittany Barker, Alexa Norton et al.•ARTICLE•International Journal of Drug…•2025

    Implementation and access to risk mitigation prescribing in Northern BC was limited, with region-specific applicability challenges and a health service delivery model that was not able to sufficiently meet the unique service needs of IPWUD. Demonstrating Northern ingenuity, peer groups, harm reduction community champions, and telehealth services were identified as stopgap measures that promoted access and reduced inequitable implementation within…

  • Just have this come from their prescription pad

    Celeste Macevicius, Daniel Gudiño Pérez et al.•ARTICLE•Drugs Education Prevention and…•2024

    Context In March 2020, British Columbia introduced the Risk Mitigation Guidance (RMG) to enable the prescription of pharmaceutical substitutes for the unregulated drug market to decrease overdose deaths and COVID-19 infections. This study presents health planners’ perspectives on the RMG adoption within a medicalized system of care.Methods We conducted interviews with 28 health planners to obtain their views on implementation. We undertook a them…

  • Associations of County-Level Social Determinants of Health with Covid-19 Related Hospitalization Among People with HIV

    Open Access•Jessica Y Islam, Eric Hurwitz et al.•ARTICLE•AIDS and Behavior•2024

    Individually, the COVID-19 and HIV pandemics have differentially impacted minoritized groups due to the role of social determinants of health (SDoH) in the U.S. Little is known how the collision of these two pandemics may have exacerbated adverse health outcomes. We evaluated county-level SDoH and associations with hospitalization after a COVID-19 diagnosis among people with (PWH) and without HIV (PWOH) by racial/ethnic groups. We used the U.S. N…

  • Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative

    Open Access•Thomas Patton, Jan R Böhnke et al.•ARTICLE•Quality of Life Research•2024

    We observed HSUVs for OUD that were higher than those from previous studies that had been conducted without input from people living with the condition

  • Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada

    Open Access•D G T Whitehurst, Cassandra Mah et al.•ARTICLE•Quality of Life Research•2023

    Purpose Using data from a randomized controlled trial for treatment of prescription-type opioid use disorder in Canada, this study examines sensitivity to change in three preference-based instruments [EQ-5D-3L, EQ-5D-5L, and the Health Utilities Index Mark 3 (HUI3)] and explores an oft-overlooked consideration when working with contemporaneous responses for similar questions—data quality. Methods Analyses focused on the relative abilities of thre…

  • Translating and disseminating a localised economic model to support implementation of the ‘Ending the HIV Epidemic’ initiative to public health policymakers

    Open Access•Matthew P Abrams, James Weiner et al.•ARTICLE•Evidence & Policy•2023•Referencias: 3

    To optimise acceptance and use of results from economic models, researchers should engage with local community members and public health decision makers early to understand budgetary and community priorities. Participants prioritised evidence that supports their existing strategies, considers budgets and funding streams, and improves health equity; however, real-world budget constraints and conflicting interests serve as barriers to implementing …

  • Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

    Thomas Santo, Brodie Clark et al.•ARTICLE•JAMA Psychiatry•2021

    Importance Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality. Objective To estimate the association of time receiving OAT with mortality. Data Sources The Embase, MEDLINE, and PsycINFO databases were searched t…

  • How simulation modeling can support the public health response to the opioid crisis in North America

    Open Access•Nick Bansback, Nicholas J Bansback et al.•ARTICLE•International Journal of Drug…•2021

  • Non-disclosure of drug use in outpatient health care settings

    Open Access•Lindsay A Pearce, Fahmida Homayra et al.•ARTICLE•International Journal of Drug…•2020

  • Developing a patient-reported experience questionnaire with and for people who use drugs

    Open Access•Michelle Olding, K Hayashi et al.•ARTICLE•International Journal of Drug…•2018

  • Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/Aids

    Open Access•E Krebs, Jeong Eun Min et al.•ARTICLE•AIDS and Behavior•2017

  • Initiating HCV treatment with direct acting agents in opioid agonist treatment

    Open Access•Dimitra Panagiotoglou, E Krebs et al.•ARTICLE•International Journal of Drug…•2017

  • Protocol of the impact of alternative social assistance disbursement on drug-related harm (Tasa) study

    Open Access•Lindsey Richardson, Allison Laing et al.•ARTICLE•BMC Public Health•2016

    NCT02457949 Registered 13 May 2015

  • Increased drug use and the timing of social assistance receipt among people who use illicit drugs

    Open Access•E Krebs, Linwei Wang et al.•ARTICLE•Social Science & Medicine•2016•Citada por: 1•Referencias: 46

  • Expansion of Haart Coverage Is Associated with Sustained Decreases in HIV/Aids Morbidity, Mortality and HIV Transmission

    Open Access•Julio S G Montaner, Julio Montaner et al.•ARTICLE•PLoS ONE•2014

    BACKGROUND: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. METHODS: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-rel…

  • Antiretroviral Drug Costs and Prescription Patterns in British Columbia, Canada

    Bohdan Nosyk, Julio S G Montaner et al.•ARTICLE•Medical Care•2014•Referencias: 3

    INTRODUCTION: Treatment options and therapeutic guidelines have evolved substantially since highly active antiretroviral treatment (HAART) became the standard of HIV care in 1996. We conducted the present population-based analysis to characterize the determinants of direct costs of HAART over time in British Columbia, Canada. METHODS: We considered individuals ever receiving HAART in British Columbia from 1996 to 2011. Linear mixed-effects regres…

  • Offender Diversion Into Substance Use Disorder Treatment

    M Douglas Anglin, Bohdan Nosyk et al.•ARTICLE•American Journal of Public Health•2013•Citada por: 1•Referencias: 28

    Objectives. We determined the costs and savings attributable to the California Substance Abuse and Crime Prevention Act (SACPA), which mandated probation or continued parole with substance abuse treatment in lieu of incarceration for adult offenders convicted of nonviolent drug offenses and probation and parole violators. Methods. We used individually linked, population-level administrative data to define intervention and control cohorts of offen…

  • Estimating the economic value of British Columbia's domestic cannabis market

    Open Access•Dan Werb, Bohdan Nosyk et al.•ARTICLE•International Journal of Drug…•2012

  • Determinants of the Cost of Health Services Used by Veterans With HIV

    Paul G Barnett, Adam Chow et al.•ARTICLE•Medical Care•2011

    BACKGROUND: The effect of adherence, treatment failure, and comorbidities on the cost of HIV care is not well understood. OBJECTIVE: To characterize the cost of HIV care including combination antiretroviral treatment (ART). RESEARCH DESIGN: Observational study of administrative data. SUBJECTS: Total 1896 randomly selected HIV-infected patients and 288 trial participants with multidrug-resistant HIV seen at the US Veterans Health Administration (V…

  • Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

    Open Access•Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•Canadian Journal of Public Health•2010•Referencias: 13

  • The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/Aids

    Open Access•Bohdan Nosyk, Huiying Sun et al.•ARTICLE•Quality of Life Research•2009

  • The North American Opiate Medication Initiative (Naomi)

    Open Access•Eugenia Oviedo‐Joekes, Bohdan Nosyk et al.•ARTICLE•Journal of Urban Health•2008•Citada por: 1•Referencias: 5

  • The effect of homelessness on hospitalisation among patients with HIV/Aids

    Bohdan Nosyk, Xiaobing Li et al.•ARTICLE•AIDS Care•2007

    The purpose of this study was to determine the effect of homelessness on the costs and patterns of hospitalisation in patients with HIV/AIDS. A retrospective longitudinal study design, based on medical records data covering 2,768 person-years of observation between 1997 and 2003 on patients with HIV/AIDS, was employed. A contextual measure of neighbourhood socioeconomic status (SES) was also used to uncover differences among low- and high-SES nei…

  • Increased drug use and the timing of social assistance receipt among people who use illicit drugs

    Open Access•E Krebs, Linwei Wang et al.•ARTICLE•Social Science & Medicine•2016•Citada por: 1•Referencias: 46

  • Offender Diversion Into Substance Use Disorder Treatment

    M Douglas Anglin, Bohdan Nosyk et al.•ARTICLE•American Journal of Public Health•2013•Citada por: 1•Referencias: 28

    Objectives. We determined the costs and savings attributable to the California Substance Abuse and Crime Prevention Act (SACPA), which mandated probation or continued parole with substance abuse treatment in lieu of incarceration for adult offenders convicted of nonviolent drug offenses and probation and parole violators. Methods. We used individually linked, population-level administrative data to define intervention and control cohorts of offen…

  • The North American Opiate Medication Initiative (Naomi)

    Open Access•Eugenia Oviedo‐Joekes, Bohdan Nosyk et al.•ARTICLE•Journal of Urban Health•2008•Citada por: 1•Referencias: 5

  • The effect of homelessness on hospitalisation among patients with HIV/Aids

    Bohdan Nosyk, Xiaobing Li et al.•ARTICLE•AIDS Care•2007

    The purpose of this study was to determine the effect of homelessness on the costs and patterns of hospitalisation in patients with HIV/AIDS. A retrospective longitudinal study design, based on medical records data covering 2,768 person-years of observation between 1997 and 2003 on patients with HIV/AIDS, was employed. A contextual measure of neighbourhood socioeconomic status (SES) was also used to uncover differences among low- and high-SES nei…

  • The North American Opiate Medication Initiative (Naomi)

    Open Access•Eugenia Oviedo‐Joekes, Bohdan Nosyk et al.•ARTICLE•Journal of Urban Health•2008•Citada por: 1•Referencias: 5

  • The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/Aids

    Open Access•Bohdan Nosyk, Huiying Sun et al.•ARTICLE•Quality of Life Research•2009

  • Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

    Open Access•Eugenia Oviedo‐Joekes, Eugenia Oviedo-Joekes et al.•ARTICLE•Canadian Journal of Public Health•2010•Referencias: 13

  • Determinants of the Cost of Health Services Used by Veterans With HIV

    Paul G Barnett, Adam Chow et al.•ARTICLE•Medical Care•2011

    BACKGROUND: The effect of adherence, treatment failure, and comorbidities on the cost of HIV care is not well understood. OBJECTIVE: To characterize the cost of HIV care including combination antiretroviral treatment (ART). RESEARCH DESIGN: Observational study of administrative data. SUBJECTS: Total 1896 randomly selected HIV-infected patients and 288 trial participants with multidrug-resistant HIV seen at the US Veterans Health Administration (V…

  • Estimating the economic value of British Columbia's domestic cannabis market

    Open Access•Dan Werb, Bohdan Nosyk et al.•ARTICLE•International Journal of Drug…•2012

  • Offender Diversion Into Substance Use Disorder Treatment

    M Douglas Anglin, Bohdan Nosyk et al.•ARTICLE•American Journal of Public Health•2013•Citada por: 1•Referencias: 28

    Objectives. We determined the costs and savings attributable to the California Substance Abuse and Crime Prevention Act (SACPA), which mandated probation or continued parole with substance abuse treatment in lieu of incarceration for adult offenders convicted of nonviolent drug offenses and probation and parole violators. Methods. We used individually linked, population-level administrative data to define intervention and control cohorts of offen…

  • Expansion of Haart Coverage Is Associated with Sustained Decreases in HIV/Aids Morbidity, Mortality and HIV Transmission

    Open Access•Julio S G Montaner, Julio Montaner et al.•ARTICLE•PLoS ONE•2014

    BACKGROUND: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. METHODS: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-rel…

  • Antiretroviral Drug Costs and Prescription Patterns in British Columbia, Canada

    Bohdan Nosyk, Julio S G Montaner et al.•ARTICLE•Medical Care•2014•Referencias: 3

    INTRODUCTION: Treatment options and therapeutic guidelines have evolved substantially since highly active antiretroviral treatment (HAART) became the standard of HIV care in 1996. We conducted the present population-based analysis to characterize the determinants of direct costs of HAART over time in British Columbia, Canada. METHODS: We considered individuals ever receiving HAART in British Columbia from 1996 to 2011. Linear mixed-effects regres…

  • Protocol of the impact of alternative social assistance disbursement on drug-related harm (Tasa) study

    Open Access•Lindsey Richardson, Allison Laing et al.•ARTICLE•BMC Public Health•2016

    NCT02457949 Registered 13 May 2015

  • Increased drug use and the timing of social assistance receipt among people who use illicit drugs

    Open Access•E Krebs, Linwei Wang et al.•ARTICLE•Social Science & Medicine•2016•Citada por: 1•Referencias: 46

  • Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/Aids

    Open Access•E Krebs, Jeong Eun Min et al.•ARTICLE•AIDS and Behavior•2017

  • Initiating HCV treatment with direct acting agents in opioid agonist treatment

    Open Access•Dimitra Panagiotoglou, E Krebs et al.•ARTICLE•International Journal of Drug…•2017

  • Developing a patient-reported experience questionnaire with and for people who use drugs

    Open Access•Michelle Olding, K Hayashi et al.•ARTICLE•International Journal of Drug…•2018

  • Non-disclosure of drug use in outpatient health care settings

    Open Access•Lindsay A Pearce, Fahmida Homayra et al.•ARTICLE•International Journal of Drug…•2020

  • Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

    Thomas Santo, Brodie Clark et al.•ARTICLE•JAMA Psychiatry•2021

    Importance Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality. Objective To estimate the association of time receiving OAT with mortality. Data Sources The Embase, MEDLINE, and PsycINFO databases were searched t…

  • How simulation modeling can support the public health response to the opioid crisis in North America

    Open Access•Nick Bansback, Nicholas J Bansback et al.•ARTICLE•International Journal of Drug…•2021

  • Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada

    Open Access•D G T Whitehurst, Cassandra Mah et al.•ARTICLE•Quality of Life Research•2023

    Purpose Using data from a randomized controlled trial for treatment of prescription-type opioid use disorder in Canada, this study examines sensitivity to change in three preference-based instruments [EQ-5D-3L, EQ-5D-5L, and the Health Utilities Index Mark 3 (HUI3)] and explores an oft-overlooked consideration when working with contemporaneous responses for similar questions—data quality. Methods Analyses focused on the relative abilities of thre…

  • Translating and disseminating a localised economic model to support implementation of the ‘Ending the HIV Epidemic’ initiative to public health policymakers

    Open Access•Matthew P Abrams, James Weiner et al.•ARTICLE•Evidence & Policy•2023•Referencias: 3

    To optimise acceptance and use of results from economic models, researchers should engage with local community members and public health decision makers early to understand budgetary and community priorities. Participants prioritised evidence that supports their existing strategies, considers budgets and funding streams, and improves health equity; however, real-world budget constraints and conflicting interests serve as barriers to implementing …

  • Just have this come from their prescription pad

    Celeste Macevicius, Daniel Gudiño Pérez et al.•ARTICLE•Drugs Education Prevention and…•2024

    Context In March 2020, British Columbia introduced the Risk Mitigation Guidance (RMG) to enable the prescription of pharmaceutical substitutes for the unregulated drug market to decrease overdose deaths and COVID-19 infections. This study presents health planners’ perspectives on the RMG adoption within a medicalized system of care.Methods We conducted interviews with 28 health planners to obtain their views on implementation. We undertook a them…

  • Associations of County-Level Social Determinants of Health with Covid-19 Related Hospitalization Among People with HIV

    Open Access•Jessica Y Islam, Eric Hurwitz et al.•ARTICLE•AIDS and Behavior•2024

    Individually, the COVID-19 and HIV pandemics have differentially impacted minoritized groups due to the role of social determinants of health (SDoH) in the U.S. Little is known how the collision of these two pandemics may have exacerbated adverse health outcomes. We evaluated county-level SDoH and associations with hospitalization after a COVID-19 diagnosis among people with (PWH) and without HIV (PWOH) by racial/ethnic groups. We used the U.S. N…

  • Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative

    Open Access•Thomas Patton, Jan R Böhnke et al.•ARTICLE•Quality of Life Research•2024

    We observed HSUVs for OUD that were higher than those from previous studies that had been conducted without input from people living with the condition

  • Implementation of risk mitigation prescribing during dual public health emergencies

    Open Access•Brittany Barker, Alexa Norton et al.•ARTICLE•International Journal of Drug…•2025

    Implementation and access to risk mitigation prescribing in Northern BC was limited, with region-specific applicability challenges and a health service delivery model that was not able to sufficiently meet the unique service needs of IPWUD. Demonstrating Northern ingenuity, peer groups, harm reduction community champions, and telehealth services were identified as stopgap measures that promoted access and reduced inequitable implementation within…

Medicine (22 obras) · HIV, Drug Use, Sexual Risk (13 obras) · Environmental health (10 obras) · Internal Medicine (10 obras) · Psychiatry (9 obras) · Public health (9 obras) · HIV/AIDS Research and Interventions (8 obras) · Nursing (8 obras) · Opioid Use Disorder Treatment (8 obras) · Family medicine (7 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae